Joint involvement is common and disabling in systemic sclerosis (SSc). Of patients with SSc, 46–97% complain about joint stiffness or pain, and up to 30% exhibit inflammatory clinical signs.
RMDs are highly prevalent and significantly affect activity limitations and participation restrictions. More effort is needed to improve care and research in this field.